Skip to content

Clinical trials

Phase 3 Graves Ophthalmopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Phase: Phase 3 Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20151
20172
20182
20212
20223
20236
202410
20255
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting7
Active, not recruiting7
Terminated4
Not yet recruiting4
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Viridian Therapeutics, Inc.8
Minghui Pharmaceutical (Hangzhou) Ltd6
Amgen3
Immunovant Sciences GmbH3
Beijing Kanghong Biological Medicine Co., Ltd.2
Hoffmann-La Roche2
Innovent Biologics (Suzhou) Co. Ltd.2
Medical University of Vienna2
University of Pisa2
argenx2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy42
Graves Disease6
Autoimmune Diseases3
Exophthalmos2
Dry Eye Syndromes1
Hashimoto Disease1

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.